Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/1992
10/29/1992CA2107790A1 Compounds for inhibition of protein methylation
10/29/1992CA2106874A1 Method for detecting and localizing tissues having neurokinine 1 receptors
10/28/1992EP0504291A4 Novel proteins with oncostatin m activity and process for their preparation
10/28/1992EP0441832A4 Composition and treatment with biologically active peptides and certain anions
10/28/1992EP0235205B1 Peptide analogues of mammalian insulin-like growth factor-1
10/28/1992CN1018825B Process for preparation of poly-4-aminopyrrole-2-carboxamido derivatives
10/27/1992US5159079 2-piperidones as intermediates for 5-deaza-10-oxo- and 5-deaza-10-thio-5,6,7,8-tetrahydrofolic acids
10/27/1992US5158977 Antioxidant; preventive treatment of cutaneous inflammations and allergies
10/27/1992US5158776 Includes microcrystalline cellulose
10/27/1992US5157894 Orientation and loading device for vials in general and syringe vials in particular
10/27/1992CA1309407C Cinnoline-carboxamides and process for their preparation
10/27/1992CA1309400C 6- or 7-methylenandrosta-1,4-diene-3,17-dione derivatives and process for their preparation
10/27/1992CA1309346C Pharmaceutical administration systems containing chemotactic peptides
10/26/1992WO1992019732A1 Closed sense and antisense oligonucleotides and uses thereof
10/26/1992CA2102229A1 Closed sense and antisense oligonucleotides and uses thereof
10/25/1992WO1992019254A1 α-SUBSTITUTED POLYPEPTIDES HAVING THERAPEUTIC ACTIVITY
10/25/1992CA2106764A1 Ó-substituted polypeptides having therapeutic activity
10/23/1992WO1992018483A1 Quinoline derivatives
10/23/1992CA2108971A1 Quinoline derivatives
10/21/1992EP0509656A1 Compositions of phytosterols and phytosterolins as immunmodulators
10/21/1992EP0509643A1 Anti-cancer compounds
10/21/1992EP0509553A1 Anti-lymphotoxin antibody, its production and use
10/21/1992EP0509088A1 1,4-bis-(amino-hydroxyalkylamino)-anthraquinones for inhibiting protein kinase c
10/21/1992EP0509056A1 Target-specific, cytotoxic, recombinant pseudomonas exotoxin
10/21/1992EP0508983A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
10/21/1992EP0481000A4 Receptors for fibroblast growth factors
10/20/1992US5157140 Esters of myo-inositol phosphate
10/20/1992US5157106 N-terminal deletions of lymphotoxin, their preparation and use
10/20/1992US5157104 Antitumor, anticarcinogenic agents
10/20/1992CA2064933A1 Carrier protein
10/20/1992CA1309026C Stable 5-fluorouracil compositions
10/19/1992WO1992018522A1 Oligodeoxynucleotides and oligonucleotides useful as decoys for proteins which selectively bind to defined dna sequences
10/19/1992CA2106386A1 Oligodeoxynucleotides and oligonucleotides useful as decoys for proteins which selectively bind to defined dna sequences
10/18/1992WO1992018498A1 Pyrimidine derivatives for enhancing antitumor activity
10/18/1992CA2108561A1 Pyrimidine derivatives for enhancing antitumor activity
10/17/1992WO1992018481A1 Styryl-substituted heteroaryl compounds which inhibit egf receptor tyrosine kinase
10/17/1992CA2108367A1 Styryl-substituted heteroaryl compounds which inhibit egf receptor tyrosine kinase
10/16/1992WO1992018146A1 Novel biologically active peptide compositions and uses therefor
10/16/1992CA2083594A1 Biologically active peptide compositions and uses therefor
10/15/1992WO1992017505A1 Monoclonal antibodies to stem cell factor receptors
10/15/1992WO1992017487A1 5'-phosphatidyl-5-fluorouridine derivative
10/15/1992WO1992017453A1 Bis-naphthalimides containing amino-acid derived linkers as anticancer agents
10/15/1992WO1992017199A1 Compositions and methods for treating small cell and nonsmall cell lung cancers
10/15/1992WO1992017198A1 Dna and amino acid sequence specific for natural killer cells
10/15/1992WO1992017190A1 Dry starch-iodine pharmaceutical formulations
10/15/1992WO1992007939A3 Polypeptide with 46kd hmfg differentiation antigen binding specificity
10/14/1992EP0508798A1 Cholecystokinin antagonists
10/14/1992EP0508797A1 Cholecystokinin antagonists
10/14/1992EP0508796A1 Cholecystokinin antagonists
10/14/1992EP0508792A1 Anti-tumor and anti-psoriatic agents
10/14/1992EP0508586A1 Substituted indenyl compounds
10/14/1992EP0507948A1 Monoclonal antibody, hybridomas, their production and use
10/14/1992EP0507938A1 Bis-(hydroxyalkylamino)-anthraquinone inhibitors of protein kinase c
10/14/1992EP0303681B1 Immunosuppression in immunotoxin based human therapy
10/14/1992CN1018649B Immunoglobulin conjugates
10/14/1992CN1018640B Process for the preparation of compounds for the induction of in vivo and in vitro production of cytokines
10/13/1992US5155249 Differentiating neoplastic cells, treating psoriasis, immune or inflammatory diseases
10/13/1992US5155210 Produce localized cytotoxic effects on target cells; antitumor and anticarcinogenic agents
10/13/1992US5155107 17β-substituted-4-aza-5α-androstan-3-one derivatives and process for their preparation
10/13/1992CA1308730C Platinum coordination compounds
10/13/1992CA1308724C Synthesis of cisplatinum analogs
10/12/1992WO1992018507A1 Anti-tumor and anti-psoriatic agents
10/12/1992CA2108146A1 Anti-tumor and anti-psoriatic agents
10/11/1992CA2065704A1 Cholecystokinin antagonists
10/11/1992CA2065703A1 Cholecystokinin antagonists
10/07/1992EP0507556A1 Silyl ethers of rapamycin
10/07/1992EP0507337A2 Novel erucyl, brassidyl and nervonyl derivatives
10/07/1992EP0506854A1 An improved toxin for construction of immunotoxins
10/07/1992EP0506830A1 Uncharged morpholino-based polymers having phosphorous-containing chiral intersubunit linkages
10/07/1992EP0506815A1 Mucin nucleotides
10/06/1992US5153012 Mixing beta-carotene with anti-oxidative vitamin C, vitamin B2 and vitamin E to minimize the loss of carotene
10/06/1992CA1308417C Process for the preparation of baccatine iii and deacetyl-10-baccatine iii
10/02/1992CA2063962A1 Silyl ethers of rapamycin
10/01/1992WO1992016600A1 Process for the extraction of peat and apparatus for carrying out the process
10/01/1992WO1992016553A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
10/01/1992WO1992016517A1 Pharmaceutical xanthone derivatives
10/01/1992WO1992004048A3 Inhibition of metastasis potential and invasiveness by oligosaccharides or oligosaccharide antigens or antibodies
10/01/1992CA2083060A1 Process for the extraction of peat and apparatus for carrying out the process
09/1992
09/30/1992WO1992017181A1 Pharmaceutical compositions and methods for preventing skin tumor formation and causing regression of existing tumors
09/30/1992EP0506628A2 Aminoacyl and oligopeptidyl derivatives of allopurinol exhibiting immunostimulatory activity, and pharmaceutical formulations containing these substances
09/30/1992EP0506008A1 Bis-naphthalimides containing amino-acid derived linkers as anticancer agents
09/30/1992EP0505680A1 Octapeptide or heptapeptide derivatives, a process for preparing them as well as medicaments containing these compounds and the use of them
09/30/1992EP0505640A1 Improved therapeutic method
09/30/1992EP0505487A1 Growth arrest of proliferating cells by transglutaminase inhibitors
09/30/1992EP0505400A1 N-substituted naphthalamides, their production and use
09/30/1992EP0505357A1 Method for antibody targeting of diagnostic or therapeutic agents
09/30/1992CN1064863A Pharmaceutical preparation containing functional vinyl pyrrole, use thereof in preparing medicine, vinyl pyrrole self and process for preparing them
09/30/1992CA2107218A1 Pharmaceutical compositions and methods for preventing skin tumor formation and causing regression of existing tumors
09/29/1992US5151360 Antitumor agents or anticarcinogenic agents
09/29/1992US5151352 Culture of Streptomyces to produce clerodane diterpene derivative
09/29/1992CA1308102C Water soluble camptothecin analogs
09/28/1992WO1992017454A1 Bis-naphthalimides containing amide and thioamide linkers as anticancer agents
09/28/1992CA2106996A1 Bis-naphthalimides containing amide and thioamide linkers as anticancer agents
09/23/1992WO1992016513A1 New compounds for use in the treatment of cancer
09/23/1992EP0505220A1 New compounds for use in the treatment of cancer
09/23/1992EP0505148A1 Stimulating factor of the neu receptor
09/23/1992EP0505047A1 Rearranged taxol compounds and method of using in testing of in vivo activity
09/23/1992EP0504695A1 New carboxamides, their preparation and pharmaceutical compositions containing them
09/23/1992EP0504350A1 Antibodies directed against cd3
09/23/1992EP0504339A1 USE OF RADIOACTIVE METAL ION COMPLEXES WITH all-cis-1,3,5-TRIAMINO-2,4,6-CYCLOHEXANTRIOL AND THEIR DERIVATES FOR X-RAY DIAGNOSIS AND IN TUMOR THERAPY AS WELL AS FOR PRODUCING X-RAY DIAGNOSTIC AND TUMOR THERAPY AGENTS
1 ... 2135 2136 2137 2138 2139 2140 2141 2142 2143 2144 2145 2146 2147 2148 2149 2150 2151 2152 2153 2154 2155 ... 2211